Literature DB >> 23306808

Detection of infarct size safety threshold for left ventricular ejection fraction impairment in acute myocardial infarction successfully treated with primary percutaneous coronary intervention.

Roberto Sciagrà1, Fabrizio Cipollini, Valentina Berti, Angela Migliorini, David Antoniucci, Alberto Pupi.   

Abstract

PURPOSE: In acute myocardial infarction (AMI) treated by primary percutaneous coronary intervention (PCI), there is a direct relationship between myocardial damage and consequent left ventricular (LV) functional impairment. It is however unclear whether there is a safety threshold below which infarct size does not significantly affect LV ejection fraction (EF). The aim of this study was to evaluate the relationship between infarct size and LVEF in AMI patients treated by successful PCI using a specific statistical approach to identify a possible safety threshold.
METHODS: Among patients with recent AMI submitted to perfusion gated single photon emission computed tomography (SPECT) to define the infarct size, the data of 427 subjects with sizable infarct size were considered. The relationship between infarct size and LVEF was analysed using a simple segmented regression (SSR) model and an iterative algorithm based on robust least squares (RLS) for parameter estimation.
RESULTS: The RLS algorithm detected two break points in the SSR model, set at infarct size values of 11.0 and 51.5 %. Because the slope coefficients of the two extreme segments of the regression line were not significant, by constraining such segments to zero slope in the SSR model, the lower break point was identified at infarct size = 8 % and the upper one at 45 %.
CONCLUSION: Using a rigorous statistical approach, it is possible to demonstrate that below a threshold of 8 % the infarct size apparently does not affect the LVEF and therefore a safety threshold could be set at this value. Furthermore, the same analysis suggests that the relationship between infarct size and LVEF impairment is lost for an infarct size > 45 %.

Entities:  

Mesh:

Year:  2013        PMID: 23306808     DOI: 10.1007/s00259-012-2329-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  22 in total

1.  Estimating regression models with unknown break-points.

Authors:  Vito M R Muggeo
Journal:  Stat Med       Date:  2003-10-15       Impact factor: 2.373

2.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

Authors: 
Journal:  N Engl J Med       Date:  1985-04-04       Impact factor: 91.245

Review 3.  Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications.

Authors:  Han W Kim; Afshin Farzaneh-Far; Raymond J Kim
Journal:  J Am Coll Cardiol       Date:  2009-12-29       Impact factor: 24.094

4.  Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction.

Authors:  Yuri B Pride; Evan Appelbaum; Erin E Lord; Sarah Sloan; Christopher P Cannon; Marc S Sabatine; C Michael Gibson
Journal:  Am J Cardiol       Date:  2009-06-17       Impact factor: 2.778

5.  Determinants of infarct size in reperfusion therapy for acute myocardial infarction.

Authors:  T F Christian; R S Schwartz; R J Gibbons
Journal:  Circulation       Date:  1992-07       Impact factor: 29.690

6.  In vitro validation of a simple tomographic technique for estimation of percentage myocardium at risk using methoxyisobutyl isonitrile technetium 99m (sestamibi).

Authors:  M K O'Connor; T Hammell; R J Gibbons
Journal:  Eur J Nucl Med       Date:  1990

7.  Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction: comparison with single-photon emission tomography using Tc99m-sestamibi.

Authors:  Tareq Ibrahim; Stephan G Nekolla; Mira Hörnke; Hubertus P Bülow; Josef Dirschinger; Albert Schömig; Markus Schwaiger
Journal:  J Am Coll Cardiol       Date:  2005-02-15       Impact factor: 24.094

8.  Determinants of final infarct size and incidence of aborted infarction in patients treated with primary coronary intervention and adjunctive abciximab therapy.

Authors:  R Sciagrà; G Parodi; B Sotgia; D Antoniucci; A Pupi
Journal:  Nuklearmedizin       Date:  2008       Impact factor: 1.379

9.  Relationship of infarct size and severity versus left ventricular ejection fraction and volumes obtained from 99mTc-sestamibi gated single-photon emission computed tomography in patients treated with primary percutaneous coronary intervention.

Authors:  Roberto Sciagrà; Alessio Imperiale; David Antoniucci; Angela Migliorini; Guido Parodi; Giannetto Comis; Alberto Pupi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-03-05       Impact factor: 9.236

10.  Variability of left ventricular ejection fraction and volumes with quantitative gated SPECT: influence of algorithm, pixel size and reconstruction parameters in small and normal-sized hearts.

Authors:  Anne-Sophie Hambye; Ann Vervaet; André Dobbeleir
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-31       Impact factor: 9.236

View more
  1 in total

1.  Therapeutic effects of percutaneous coronary intervention on acute myocardial infarction complicated with multiple organ dysfunction syndrome.

Authors:  Dajun Qian; Daqiong Zhou; Huan Liu; Di Xu
Journal:  Pak J Med Sci       Date:  2019 Nov-Dec       Impact factor: 1.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.